Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120

Article Abstract:

CD4, a cell-surface receptor for class II major histocompatibility antigens, has achieved notoriety by also being the primary receptor for the AIDS virus, HIV. Several major experimental therapeutic protocols hinge upon trying to interfere with the binding of the virus to CD4, the first step in the infectious process. While most such experiments focus upon the use of antibodies to block CD4, or using an excess of recombinant CD4 to swamp the virus, researchers have now identified a set of organic compounds which block the binding of the virus. The molecules are N-carbomethoxycarbonyl-prolyl-phenylalanyl benzyl esters, more simply called CPFs. These molecules bind to gp120, which is the viral molecule responsible for binding to the receptors on the target cell. One particular CPF, termed CPF(DD) was found to block viral binding without interfering with the normal function of the T cell. In tissue culture experiments, CPF(DD) was shown to prevent the spread of infection from cell to cell. However, the production of viral proteins by cells which have already been infected by the AIDS virus is not affected by this compound. In principle, however, the binding of CPFs to the viral protein could be exploited to deliver other reagents specifically to infected cells while leaving uninfected cells alone. The ability of CPFs to bind to gp120 indicates that these agents have considerable therapeutic potential for the treatment of HIV infection. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Finberg, Robert W., Schreiber, Stuart L., Diamond, David C., Mitchell, Darren B., Rosenstein, Yvonne, Soman, Gopalan, Norman, Thea C., Burakoff, Steven J.
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1990
Physiological aspects, Cell receptors, AIDS (Disease), gp120 (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin

Article Abstract:

Experiments were carried out to evaluate the effectiveness of one approach to preventing infection by human immunodeficiency virus type 1 (HIV-1), which is associated with AIDS. This virus binds to the CD4 receptor, a molecule on T cells, causing them to be activated. (T cells are the main cell type of the cellular immune system.) One of the signs of this activation is the expression of the receptor for interleukin-2 (the IL-2 receptor); when this occurs, HIV-1 begins to replicate and infection proceeds. In these experiments, a toxin (diphtheria toxin) was joined to IL-2 to produce a molecule (DAB IL-2) that would bind to the IL-2 receptor and kill the cells on which the receptor was expressed. T cells were infected with HIV-1 under laboratory conditions, then exposed to DAB-IL2. This led to the elimination of the infected cells, while uninfected T cells were not eliminated. Other tests of the selectivity of this effect for infected cells were carried out. In addition, the toxin prevented HIV-1 from producing certain proteins and new infectious viral particles. The use of targeted toxins, such as that described here, may be effective in curbing the initial spread of HIV infection. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Finberg, Robert W., Strom, Terry B., Soman, Gopalan, Wahl, Sharon M., Allen, Janice B., Murphy, John R., Nichols, Jean C.
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1991
HIV (Viruses), HIV, Interleukin-2, Drug receptors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints

Article Abstract:

A new kinase family has been cloned that participates in a variety of cellular functions including meiotic and V(D)J recombination, cell cycle progression and chromosome maintenance and repair. When functioning improperly, the new kinase family can cause cancer and other disorders.

Author: Schreiber, Stuart L., Keith, Curtis T.
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
Research, Cellular control mechanisms, Cell regulation, Protein kinases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prevention, HIV infection, HIV infections
Similar abstracts:
  • Abstracts: Mediated conditioning and retrospective revaluation with LICL then flavour pairings. Contextual control of appetitive conditioning: influence of a contextual stimulous generated by a partial reinforcement procedure
  • Abstracts: Performance and simulation of ozone absorption and reactions in a stirred-tank reactor. The influence of sulfide on solid-phase mercury bioavailability for methylation by pure cultures of desulfobulbus propionicus (1pr3)
  • Abstracts: Planning for prestige: hope for getting the oil out of a sunken tanker. Troubles at the edge: at their borders, reserves may increase animal deaths
  • Abstracts: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Fetal nerve grafts show promise in Parkinson's
  • Abstracts: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Inheritance of proliferative breast disease in breast cancer kindred
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.